HELPING LABS MEET THEIR SARS-COV-2 TESTING CHALLENGES

LEAD TIME TO DELIVER SARS-COV-2 TEST SOLUTION

RT-PCR TEST

0Day

AUTOMATED RNA EXTRACTION EQUIPMENT

0Days

COVID-19 testing has been limited by a global shortage of critical supplies(1). PerkinElmer is extending support to mitigate the issue by providing a live stream of RT-PCR test and automated RNA extraction equipment lead time for setting up labs to process 50,000 samples each day. The lead time will be updated regularly based on inventory and demand.

Contact Us To Overcome Your SARS-CoV-2 Challenges

LEAD TIME TO DELIVER SARS-COV-2 TEST SOLUTION

0Day
RT-PCR TEST
0Days
AUTOMATED RNA EXTRACTION EQUIPMENT

COVID-19 testing has been limited by a global shortage of critical supplies(1). PerkinElmer is extending support to mitigate the issue by providing a live stream of RT-PCR test and automated RNA extraction equipment lead time for setting up labs to process 50,000 samples each day. The lead time will be updated regularly based on inventory and demand.

Contact Us To Overcome Your SARS-CoV-2 Challenges

IMPROVING THE EFFICIENCY OF SARS-COV-2 TESTING

We are here to help laboratories overcome their SARS-CoV-2 testing challenges so they can better address the world’s urgent public health concerns. We are working closely with laboratories around the world to deliver the nucleic acid isolation, automation, real-time PCR, antibody testing, and vaccine development solutions they need to rapidly respond to these challenges. Our top priority is to provide the technology and support to meet these needs.

We help labs:

  • Increase throughput
  • Improve accuracy
  • Increase efficiency
  • Enhance laboratory safety

Protect Your Lab from SARS-CoV-2 Testing Supply Chain Interruptions

Supply chain interruptions can have a significant impact on a lab’s SARS-CoV-2 testing capacity, delaying, decreasing, or even preventing a lab’s ability to perform testing. If your testing has been disrupted due to your inability to obtain needed resources, a shift in testing methodology can give you the flexibility you need to better react to the world’s rapidly changing needs.

To address growing supply constraints worldwide, PerkinElmer has expanded the production capacity of our coronavirus workflow components including reagents, instruments, and consumables. We have the capability to ship millions of our extraction and RT-PCR tests to our customers. In addition, PerkinElmer is one of the few companies with single-source SARS-CoV-2 workflows giving customers the ability to order all of the components from one source.

You Are Not Alone

PerkinElmer is a supplier you can depend on to eliminate your supply chain nightmares. We are there for you. SARS-CoV-2 testing technical support experts are available day and night by email to ensure you get the help you need, when you need it.

DIAGNOSTIC PRODUCTS

Simultaneous COVID-19, Flu, and RSV Test – CE-IVD
Detect and differentiate SARS-CoV-2, influenza A, influenza B, and RSV in a single sample with the CE-IVD marked PKamp Respiratory SARS-CoV-2 RT-PCR Panel. This workflow enables labs to conserve resources while testing a single sample for multiple pathogens.


PerkinElmer® New Coronavirus Nucleic Acid Detection Kit Authorized Under FDA EUA
The PerkinElmer® New Coronavirus Nucleic Acid Detection Kit is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in human oropharyngeal, nasopharyngeal, and anterior nasal swab samples. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, to perform high complexity tests, or by similarly qualified non-U.S. laboratories.


PerkinElmer® SARS-CoV-2 Real-time RT-PCR Assay CE-IVD

Pool your SARS-CoV-2 samples from asymptomatic or symptomatic patients with the CE-IVD marked PerkinElmer® SARS-CoV-2 Real-time RT-PCR assay. Saliva samples are also supported in addition to swabs.


COVID-19 Lab-In-A-Lab™ Testing Solution
Increase your SARS-CoV-2 testing capabilities with the COVID-19 Lab-In-A-Lab™ testing solution, a full-service turnkey testing option embedded in your CLIA certified lab.

sars-cov-2

RUO PRODUCTS

PerkinElmer® SARS-CoV-2 Nucleic Acid Detection Kit (RUO)
Designed to streamline SARS-CoV-2 laboratory developed testing, the PerkinElmer SARS-CoV-2 Nucleic Acid Detection Kit (RUO) is an real-time RT-PCR-based assay.


Viral RNA Isolation
The PerkinElmer chemagic Viral DNA/ RNA 300 Kit H96 and the chemagic 360 instrument deliver fast, high throughput extraction of high-quality RNA for use with PCR-based detection of SARS-CoV-2. With this setup, RNA can be extracted from 96 samples per hour, producing high quality RNA.


Automation of RNA Isolation Setup and PCR Assay Setup
Specialized JANUS® G3 automated workstations are now available to optimize your SARS-CoV-2 testing workflow. With the ability to automate sample prep for RNA isolation and PCR setup these workstations are designed to be used with any SARS-CoV-2 viral extraction and detection assay chemistry.


Mobile Monitoring of SARS-CoV-2 Testing
PerkinElmer has coupled the new PKeye™ Mobile Operations Monitor with the JANUS® G3 Primary Sample reformatter and PCR liquid handler to enable your lab to increase the consistency and reliability of your automated SARS-CoV-2 detection workflow.


explorer™ Workstations for End-to-End SARS-CoV-2 Testing
PerkinElmer enables labs to maximize the efficiency of their SARS-CoV-2 RT-PCR and ELISA testing with scalable and modular explorer workstations and a reliable supply of reagents and consumables, ensuring they can meet their ever-changing testing needs.


BeadBoost Bead Mill Homogenizer
By homogenizing saliva samples prior to processing with the BeadBoost Bead Mill homogenizer you can increase the sensitivity and ease of processing of SARS-CoV-2 testing from saliva samples.

Overview of SARS-CoV-2 Antibody Assays
Explore PerkinElmer’s immunoassays optimized for use with varied samples types, throughputs, run times, and targets.


PerkinElmer® GSP®/DELFIA® Anti-SARS-CoV-2 IgG Kit CE-IVD
The PerkinElmer® GSP®/DELFIA® Anti-SARS-CoV-2 IgG kit delivers qualitative detection of human IgG antibodies against SARS-CoV-2 in dried blood spots, plasma, and serum to identify individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection.


PerkinElmer® SuperFlex™ Anti-SARS-CoV-2 IgG Kit CE-IVD
Achieve fast, hands-free anti-SARS-CoV-2 IgG antibody detection using direct chemiluminescence technology with the SuperFlex™ Anti-SARS-CoV-2 kit. Samples are run on the SuperFlex™ Chemiluminescent Immunoassay system, allowing hands-free analysis of up to 48 samples per hour to quickly identify recent or prior infections.


SuperFlex™ Chemiluminescent Immunoassay System CE-IVD
The SuperFlex™ Chemiluminescent Immunoassay system delivers fast, hands-free analysis of small biological molecules using labeled antibodies and antigens.


SARS-CoV-2 ELISA Test Systems from EUROIMMUN

Simplifying the Analysis of the SARS-CoV-2 Virus with NGS
PerkinElmer’s NGS workflows enable effective and high-throughput detection of the SARS-CoV-2 virus, surveillance and epidemiological studies, the tracking of mutational changes in the virus, unbiased pathogen discovery, and the analysis of potential susceptibility and human response to SARS-CoV-2 infection.

WORKFLOWS

Improve the Productivity of Real-time SARS-CoV-2 RT-PCR Testing Workflow

sars-cov-2 workflow


SARS-CoV-2 Testing Saliva Workflow
Optimize your workflow for SARS-CoV-2 testing of saliva samples to simplify sample processing and increase your testing sensitivity.


Biosurveillance of Wastewater for Coronavirus Workflows


Speed Up Your Nucleic Acid and Protein Analysis for SARS-CoV-2 Vaccine Development


SARS-CoV-2 Surface Testing
Streamline your surface testing of SARS-Cov-2 with an automated workflow using proven and sensitive PerkinElmer technology.

SOLUTIONS FOR DIFFERENT SARS-COV-2 APPLICATIONS

Real-time PCR Assay Antibody Assay Targeted Sequencing WGS/Shotgun Sequencing Expression Analysis
Detect active infections X
Detect virus X X X
Perform surveillance & epidemiology X X X
Detect patient immunity X
Speed & TAT X X
Track mutations X X
Discovery X X
Analyze human response to disease X X X

SEE HOW OUR SOLUTIONS ARE HELPING LABS OVERCOME THEIR SARS-COV-2 TESTING CHALLENGES

SARS-CoV-2 Testing in California

Governor Newsom Announces Major Plan to More than Double State’s Testing Capacity, Reduce Turnaround Time

SARS-CoV-2 Testing in Wales

Over 200 Jobs Announced as Part of the Welsh Lighthouse Lab Facility

SARS-COV-2

Why PerkinElmer Chose TopDutch to Produce Millions of Corona Tests

SARS-COV-2 Test

‘It’s The Hunger Games for Laboratories.’ Why Some People Are Waiting Weeks for Their COVID-19 Test Results

SARS-COV-2

Scaling up RT-PCR Assays for Mass Population Screening in the Fight Against COVID-19

Sonoma County Aims to Triple Volume of Coronavirus Test Processing with New Technology

Read how FioCruiz increased their SARS-CoV-2 testing

Fiocruz implanta Unidades de Apoio ao Diagnóstico da Covid-19

Read how Texas boosted its COVID-19 testing capacity

Texas Works with ESG-friendly Testing Company PerkinElmer to Tame Pandemic

Rutgers is leveraging the explorer™ G3 workstation for SARS-CoV-2 testing of saliva samples

New Coronavirus Test Developed at Rutgers can Screen Thousands & It’s as Simple as a Spit in a Tube

sars-cov-2

Global Collaboration Establishes Wales’ National Covid-19 Testing Laboratory

sars-cov-2

Sema4 to Deliver High Capacity COVID-19 Testing in Partnership with the State of Connecticut

PERKINELMER SARS-COV-2 RESOURCES

PRESS RELEASES

PerkinElmer SARS-CoV-2 RT-PCR Assay Receives CE Mark for Saliva and Sample Pooling to Test Symptomatic and Asymptomatic Individuals

EUROIMMUN Launches Quantitative ELISA to Measure SARS-CoV-2 Antibodies Against Viral S1 Protein

PerkinElmer Receives CE Mark for Multi-analyte Respiratory Panel Including COVID-19

PerkinElmer Launches Online, Open Access COVID-19 Data Dashboards to Accelerate Antiviral Therapeutics Research

PerkinElmer COVID-19 Test Kit Receives FDA Emergency Use Authorization for Sample Pooling

PerkinElmer Receives CE Mark for Multi-analyte Respiratory Panel Including COVID-19

PerkinElmer Launches Online, Open Access COVID-19 Data Dashboards to Accelerate Antiviral Therapeutics Research

PerkinElmer Launches Modular and Scalable explorer™ Workstations for High-throughput COVID-19 Detection

PerkinElmer Launches Online, Open Access COVID-19 Data Dashboards to Accelerate Antiviral Therapeutics Research

PerkinElmer Releases New Dried Blood Spot Based COVID-19 Serology Test

Sonora Quest Collaborates with State and Health Care Leaders to Vastly Expand COVID-19 Testing Capacity in Arizona

Global Collaboration Establishes Wales’ National Covid-19 Testing Laboratory

FDA Provides Emergency Use Authorization to PerkinElmer for Serological Test to Identify COVID-19 Antibodies

EUROIMMUN is one of first European manufacturers of diagnostic tests to provide CE-marked antibody detection systems to support COVID-19 diagnostics

FDA Provides Emergency Use Authorization to PerkinElmer for COVID-19 Testing

CORONAVIRUS RESOURCES

References:

  1. COVID-19 Survey report, June 11, 2020 (https://educate.amp.org/local/catalog/view/product.php?productid=186)
Contact Us To Overcome Your SARS-CoV-2 Challenges